Skip to main content
SpringerLink
Log in

Conditions and Syndromes

  • Chapter
  • First Online:
Lower Urinary Tract Symptoms in Adults

  • 543 Accesses

Abstract

The individual lower urinary tract symptoms (LUTS) commonly occur in conjunction. Particularly important combinations may reflect associations of symptoms (e.g. overactive bladder) or a shared underlying mechanism (e.g. bladder outlet obstruction, detrusor underactivity or nocturnal polyuria). Finally, urinary retention covers a range of potential presentations and mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kuo HC. Videourodynamic analysis of pathophysiology of men with both storage and voiding lower urinary tract symptoms. Urology. 2007;70(2):272–6.

    Article  PubMed  Google Scholar 

  2. Prajapati A, Gupta S, Mistry B, Gupta S. Prostate stem cells in the development of benign prostate hyperplasia and prostate cancer: emerging role and concepts. Biomed Res Int. 2013;2013:107954.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Warren K, Burden H, Abrams P. Lower urinary tract symptom: still too much focus on the prostate? Curr Opin Urol. 2014;24(1):3–9.

    Article  PubMed  Google Scholar 

  4. Li MK, Garcia L, Patron N, Moh LC, Sundram M, Leungwattanakij S, et al. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function. BJU Int. 2008;101(2):197–202.

    PubMed  Google Scholar 

  5. Bechis SK, Otsetov AG, Ge R, Olumi AF. Personalized medicine for the management of benign prostatic hyperplasia. J Urol. 2014;192(1):16–23.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Fukuta F, Masumori N, Mori M, Tsukamoto T. Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study. BJU Int. 2012;110(7):1023–9.

    Article  PubMed  Google Scholar 

  7. Speakman M, Kirby R, Doyle S, Ioannou C. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK. BJU Int. 2015;115(4):508–19.

    Article  PubMed  Google Scholar 

  8. Parsons JK. Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep. 2010;5(4):212–8.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Altok M, Bagci O, Umul M, Gunes M, Akyuz M, Uruc F, et al. Chromosomal aberrations in benign prostatic hyperplasia patients. Investig Clin Urol. 2016;57(1):45–9.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Chughtai B, Lee R, Te A, Kaplan S. Role of inflammation in benign prostatic hyperplasia. Rev Urol. 2011;13(3):147–50.

    PubMed  PubMed Central  Google Scholar 

  11. Wen S, Chang HC, Tian J, Shang Z, Niu Y, Chang C. Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer. Am J Pathol. 2015;185(2):293–301.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Nicholson TM, Ricke WA. Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Differentiation. 2011;82(4–5):184–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Hennenberg M, Schreiber A, Ciotkowska A, Rutz B, Waidelich R, Strittmatter F, et al. Cooperative effects of EGF, FGF, and TGF-beta1 in prostate stromal cells are different from responses to single growth factors. Life Sci. 2015;123:18–24.

    Article  CAS  PubMed  Google Scholar 

  14. Bostanci Y, Kazzazi A, Momtahen S, Laze J, Djavan B. Correlation between benign prostatic hyperplasia and inflammation. Curr Opin Urol. 2013;23(1):5–10.

    Article  PubMed  Google Scholar 

  15. Gandaglia G, Briganti A, Gontero P, Mondaini N, Novara G, Salonia A, et al. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). BJU Int. 2013;112(4):432–41.

    Article  PubMed  Google Scholar 

  16. Gacci M, Corona G, Vignozzi L, Salvi M, Serni S, De Nunzio C, et al. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. BJU Int. 2015;115(1):24–31.

    Article  PubMed  Google Scholar 

  17. Choo MS, Han JH, Shin TY, Ko K, Lee WK, Cho ST, et al. Alcohol, smoking, physical activity, protein, and lower urinary tract symptoms: prospective longitudinal cohort. Int Neurourol J. 2015;19(3):197–206.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Roehrborn CG. Pathology of benign prostatic hyperplasia. Int J Impot Res. 2008;20(Suppl 3):S11–8.

    Article  PubMed  Google Scholar 

  19. Nitti VW, Tu LM, Gitlin J. Diagnosing bladder outlet obstruction in women. J Urol. 1999;161(5):1535–40.

    Article  CAS  PubMed  Google Scholar 

  20. Akikwala TV, Fleischman N, Nitti VW. Comparison of diagnostic criteria for female bladder outlet obstruction. J Urol. 2006;176(5):2093–7.

    Article  PubMed  Google Scholar 

  21. Chassagne S, Bernier PA, Haab F, Roehrborn CG, Reisch JS, Zimmern PE. Proposed cutoff values to define bladder outlet obstruction in women. Urology. 1998;51(3):408–11.

    Article  CAS  PubMed  Google Scholar 

  22. Lemack GE, Zimmern PE. Pressure flow analysis may aid in identifying women with outflow obstruction. J Urol. 2000;163(6):1823–8.

    Article  CAS  PubMed  Google Scholar 

  23. Defreitas GA, Zimmern PE, Lemack GE, Shariat SF. Refining diagnosis of anatomic female bladder outlet obstruction: comparison of pressure-flow study parameters in clinically obstructed women with those of normal controls. Urology. 2004;64(4):675–9. discussion 9-81.

    Article  PubMed  Google Scholar 

  24. Blaivas JG, Groutz A. Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology. Neurourol Urodyn. 2000;19(5):553–64.

    Article  CAS  PubMed  Google Scholar 

  25. Gravina GL, Costa AM, Ronchi P, Galatioto GP, Luana G, Vicentini C. Bladder outlet obstruction index and maximal flow rate during urodynamic study as powerful predictors for the detection of urodynamic obstruction in women. Neurourol Urodyn. 2007;26(2):247–53.

    Article  PubMed  Google Scholar 

  26. Solomon E, Yasmin H, Duffy M, Rashid T, Akinluyi E, Greenwell TJ. Developing and validating a new nomogram for diagnosing bladder outlet obstruction in women. Neurourol Urodyn. 2018;37(1):368–78.

    Article  PubMed  Google Scholar 

  27. Massey JA, Abrams PH. Obstructed voiding in the female. Br J Urol. 1988;61(1):36–9.

    Article  CAS  PubMed  Google Scholar 

  28. Leach GE, Dmochowski RR, Appell RA, Blaivas JG, Hadley HR, Luber KM, et al. Female stress urinary incontinence clinical guidelines panel summary report on surgical management of female stress urinary incontinence. The American Urological Association. J Urol. 1997;158(3 Pt 1):875–80.

    Article  CAS  PubMed  Google Scholar 

  29. Groutz A, Blaivas JG, Chaikin DC. Bladder outlet obstruction in women: definition and characteristics. Neurourol Urodyn. 2000;19(3):213–20.

    Article  CAS  PubMed  Google Scholar 

  30. Nitti VW. Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol. 2005;7(Suppl 6):S14–21.

    PubMed  PubMed Central  Google Scholar 

  31. Hickling D, Aponte M, Nitti V. Evaluation and management of outlet obstruction in women without anatomical abnormalities on physical exam or cystoscopy. Curr Urol Rep. 2012;13(5):356–62.

    Article  PubMed  Google Scholar 

  32. Edwards L, Malvern J. The urethral pressure profile: theoretical considerations and clinical application. Br J Urol. 1974;46(3):325–35.

    Article  CAS  PubMed  Google Scholar 

  33. Fowler CJ, Kirby RS. Electromyography of urethral sphincter in women with urinary retention. Lancet. 1986;1(8496):1455–7.

    Article  CAS  PubMed  Google Scholar 

  34. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn. 2002;21(2):167–78.

    Article  PubMed  Google Scholar 

  35. Carlson KV, Fiske J, Nitti VW. Value of routine evaluation of the voiding phase when performing urodynamic testing in women with lower urinary tract symptoms. J Urol. 2000;164(5):1614–8.

    Article  CAS  PubMed  Google Scholar 

  36. Groutz A, Blaivas JG, Pies C, Sassone AM. Learned voiding dysfunction (non-neurogenic, neurogenic bladder) among adults. Neurourol Urodyn. 2001;20(3):259–68.

    Article  CAS  PubMed  Google Scholar 

  37. Deindl FM, Vodusek DB, Bischoff C, Hofmann R, Hartung R. Dysfunctional voiding in women: which muscles are responsible? Br J Urol. 1998;82(6):814–9.

    Article  CAS  PubMed  Google Scholar 

  38. Patel R, Nitti V. Bladder outlet obstruction in women: prevalence, recognition, and management. Curr Urol Rep. 2001;2(5):379–87.

    Article  CAS  PubMed  Google Scholar 

  39. Kessler TM, Studer UE, Burkhard FC. The effect of terazosin on functional bladder outlet obstruction in women: a pilot study. J Urol. 2006;176(4 Pt 1):1487–92.

    Article  CAS  PubMed  Google Scholar 

  40. Fowler CJ, Kirby RS, Harrison MJ. Decelerating burst and complex repetitive discharges in the striated muscle of the urethral sphincter, associated with urinary retention in women. J Neurol Neurosurg Psychiatry. 1985;48(10):1004–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Fowler CJ, Kirby RS. Abnormal electromyographic activity (decelerating burst and complex repetitive discharges) in the striated muscle of the urethral sphincter in 5 women with persisting urinary retention. Br J Urol. 1985;57(1):67–70.

    Article  CAS  PubMed  Google Scholar 

  42. Wiseman OJ, Swinn MJ, Brady CM, Fowler CJ. Maximum urethral closure pressure and sphincter volume in women with urinary retention. J Urol. 2002;167(3):1348–51. discussion 51-2.

    Article  PubMed  Google Scholar 

  43. De Ridder D, Ost D, Bruyninckx F. The presence of Fowler’s syndrome predicts successful long-term outcome of sacral nerve stimulation in women with urinary retention. Eur Urol. 2007;51(1):229–33. discussion 33-4.

    Article  PubMed  Google Scholar 

  44. Axelrod SL, Blaivas JG. Bladder neck obstruction in women. J Urol. 1987;137(3):497–9.

    Article  CAS  PubMed  Google Scholar 

  45. Blaivas JG, Flisser A, Tash JA. Treatment of primary bladder neck obstruction in women with transurethral resection of the bladder neck. J Urol. 2004;171(3):1172–5.

    Article  PubMed  Google Scholar 

  46. Diokno AC, Hollander JB, Bennett CJ. Bladder neck obstruction in women: a real entity. J Urol. 1984;132(2):294–8.

    Article  CAS  PubMed  Google Scholar 

  47. Grivas N, Tsimaris I, Makatsori A, Hastazeris K, Kafarakis V, Stavropoulos NE. The effectiveness of Otis urethrotomy combined with six weeks urethral dilations until 40 Fr in the treatment of bladder outlet obstruction in women: a prospective study. Urol J. 2014;10(4):1063–6.

    PubMed  Google Scholar 

  48. Zhang P, Wu ZJ, Xu L, Yang Y, Zhang N, Zhang XD. Bladder neck incision for female bladder neck obstruction: long-term outcomes. Urology. 2014;83(4):762–6.

    Article  PubMed  Google Scholar 

  49. Castro-Diaz D, Taracena Lafuente JM. Detrusor-sphincter dyssynergia. Int J Clin Pract Suppl. 2006;151:17–21.

    Article  Google Scholar 

  50. Onal B, Siva A, Buldu I, Demirkesen O, Cetinel B. Voiding dysfunction due to multiple sclerosis: a large scale retrospective analysis. Int Braz J Urol. 2009;35(3):326–33.

    Article  PubMed  Google Scholar 

  51. Phelan MW, Franks M, Somogyi GT, Yokoyama T, Fraser MO, Lavelle JP, et al. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol. 2001;165(4):1107–10.

    Article  CAS  PubMed  Google Scholar 

  52. Kuo HC. Botulinum a toxin urethral injection for the treatment of lower urinary tract dysfunction. J Urol. 2003;170(5):1908–12.

    Article  CAS  PubMed  Google Scholar 

  53. Kuo HC. Botulinun a toxin urethral sphincter injection for neurogenic or nonneurogenic voiding dysfunction. Ci Ji Yi Xue Za Zhi. 2016;28(3):89–93.

    PubMed  Google Scholar 

  54. Kilicarslan H, Ayan S, Vuruskan H, Gokce G, Gultekin EY. Treatment of detrusor sphincter dyssynergia with baclofen and doxazosin. Int Urol Nephrol. 2006;38(3–4):537–41.

    CAS  PubMed  Google Scholar 

  55. Kuo HC. Videourodynamic characteristics and lower urinary tract symptoms of female bladder outlet obstruction. Urology. 2005;66(5):1005–9.

    Article  PubMed  Google Scholar 

  56. Osman NI, Mangera A, Chapple CR. A systematic review of surgical techniques used in the treatment of female urethral stricture. Eur Urol. 2013;64(6):965–73.

    Article  PubMed  Google Scholar 

  57. Petrou SP, Rogers AE, Parker AS, Green KM, McRoberts JW. Dorsal vaginal graft urethroplasty for female urethral stricture disease. BJU Int. 2012;110(11 Pt C):E1090–5.

    Article  PubMed  Google Scholar 

  58. Gormley EA. Vaginal flap urethroplasty for female urethral stricture disease. Neurourol Urodyn. 2010;29(Suppl 1):S42–5.

    Article  PubMed  Google Scholar 

  59. Uehling DT. The normal caliber of the adult female urethra. J Urol. 1978;120(2):176–7.

    Article  CAS  PubMed  Google Scholar 

  60. Tanagho EA, McCurry E. Pressure and flow rate as related to lumen caliber and entrance configuration. J Urol. 1971;105(4):583–5.

    Article  CAS  PubMed  Google Scholar 

  61. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20.

    PubMed  Google Scholar 

  62. Drake MJ. Do we need a new definition of the overactive bladder syndrome? ICI-RS 2013. Neurourol Urodyn. 2014;33(5):622–4.

    Article  PubMed  Google Scholar 

  63. Coyne KS, Sexton CC, Thompson CL, Milsom I, Irwin D, Kopp ZS, et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the epidemiology of LUTS (EpiLUTS) study. BJU Int. 2009;104(3):352–60.

    Article  PubMed  Google Scholar 

  64. Doggweiler R, Whitmore KE, Meijlink JM, Drake MJ, Frawley H, Nordling J, et al. A standard for terminology in chronic pelvic pain syndromes: a report from the chronic pelvic pain working group of the international continence society. Neurourol Urodyn. 2017;36(4):984–1008.

    Article  PubMed  Google Scholar 

  65. Chapple CR, Osman NI, Birder L, Dmochowski R, Drake MJ, van Koeveringe G, et al. Terminology report from the International Continence Society (ICS) Working Group on Underactive Bladder (UAB). Neurourol Urodyn. 2018;37(8):2928–31.

    Article  PubMed  Google Scholar 

  66. Hoag N, Gani J. Underactive bladder: clinical features, urodynamic parameters, and treatment. Int Neurourol J. 2015;19(3):185–9.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Gammie A, Kaper M, Dorrepaal C, Kos T, Abrams P. Signs and symptoms of detrusor underactivity: an analysis of clinical presentation and urodynamic tests from a large group of patients undergoing pressure flow studies. Eur Urol. 2016;69(2):361–9.

    Article  PubMed  Google Scholar 

  68. Uren AD, Drake MJ. Definition and symptoms of underactive bladder. Investig Clin Urol. 2017;58(Suppl 2):S61–S7.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Abarbanel J, Marcus EL. Impaired detrusor contractility in community-dwelling elderly presenting with lower urinary tract symptoms. Urology. 2007;69(3):436–40.

    Article  PubMed  Google Scholar 

  70. Resnick NM, Yalla SV. Detrusor hyperactivity with impaired contractile function. An unrecognized but common cause of incontinence in elderly patients. JAMA. 1987;257(22):3076–81.

    Article  CAS  PubMed  Google Scholar 

  71. Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. J Urol. 2005;174(5):1887–91.

    Article  PubMed  Google Scholar 

  72. Hill SR, Fayyad AM, Jones GR. Diabetes mellitus and female lower urinary tract symptoms: a review. Neurourol Urodyn. 2008;27(5):362–7.

    Article  PubMed  Google Scholar 

  73. Araki I, Kitahara M, Oida T, Kuno S. Voiding dysfunction and Parkinson’s disease: urodynamic abnormalities and urinary symptoms. J Urol. 2000;164(5):1640–3.

    Article  CAS  PubMed  Google Scholar 

  74. Litwiller SE, Frohman EM, Zimmern PE. Multiple sclerosis and the urologist. J Urol. 1999;161(3):743–57.

    Article  CAS  PubMed  Google Scholar 

  75. Abrams P. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int. 1999;84(1):14–5.

    Article  CAS  PubMed  Google Scholar 

  76. Fry CH, Gammie A, Drake MJ, Abrams P, Kitney DG, Vahabi B. Estimation of bladder contractility from intravesical pressure-volume measurements. Neurourol Urodyn. 2016;36(4):1009–14.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  77. Gammie A, Kitney D, Drake M, Abrams P, Fry C. The calculation and comparison of the Detrusor Contractility Parameter and Watts Factor. Neurourol Urodyn. 2018;37(8):2745–52.

    Article  PubMed  Google Scholar 

  78. Rademakers KL, Drossaerts JM, van Kerrebroeck PE, Oelke M, van Koeveringe GA. Prediction of sacral neuromodulation treatment success in men with impaired bladder emptying-time for a new diagnostic approach. Neurourol Urodyn. 2017;36(3):808–10.

    Article  PubMed  Google Scholar 

  79. Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P. The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up. BJU Int. 2004;93(6):745–50.

    Article  CAS  PubMed  Google Scholar 

  80. Gakis G, Ninkovic M, van Koeveringe GA, Raina S, Sturtz G, Rahnama’i MS, et al. Functional detrusor myoplasty for bladder acontractility: long-term results. J Urol. 2011;185(2):593–9.

    Article  PubMed  Google Scholar 

  81. Verbalis JG. Renal physiology of nocturia. Neurourol Urodyn. 2014;33(Suppl 1):S6–9.

    Article  PubMed  Google Scholar 

  82. Rittig S, Knudsen UB, Norgaard JP, Pedersen EB, Djurhuus JC. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Phys. 1989;256(4 Pt 2):F664–71.

    CAS  Google Scholar 

  83. Graugaard-Jensen C, Rittig S, Djurhuus JC. Nocturia and circadian blood pressure profile in healthy elderly male volunteers. J Urol. 2006;176(3):1034–9. discussion 9.

    Article  PubMed  Google Scholar 

  84. Negoro H, Kanematsu A, Yoshimura K, Ogawa O. Chronobiology of micturition: putative role of the circadian clock. J Urol. 2013;190(3):843–9.

    Article  PubMed  Google Scholar 

  85. Dibner C, Schibler U, Albrecht U. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol. 2010;72:517–49.

    Article  CAS  PubMed  Google Scholar 

  86. Van Kerrebroeck P, Andersson KE. Terminology, epidemiology, etiology, and pathophysiology of nocturia. Neurourol Urodyn. 2014;33(Suppl 1):S2–5.

    Article  PubMed  Google Scholar 

  87. Hofmeester I, Kollen BJ, Steffens MG, Bosch JLHR, Drake MJ, Weiss JP, et al. Impact of the International Continence Society (ICS) report on the standardisation of terminology in nocturia on the quality of reports on nocturia and nocturnal polyuria: a systematic review. BJU Int. 2015;115(4):520–36.

    Article  PubMed  Google Scholar 

  88. van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S, et al. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):179–83.

    Article  PubMed  Google Scholar 

  89. Hofmeester I, Kollen BJ, Steffens MG, Bosch JL, Drake MJ, Weiss JP, et al. The association between nocturia and nocturnal polyuria in clinical and epidemiological studies: a systematic review and meta-analyses. J Urol. 2014;191(4):1028–33.

    Article  PubMed  Google Scholar 

  90. Austin PF, Bauer SB, Bower W, Chase J, Franco I, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the Standardization Committee of the International Children’s Continence Society. J Urol. 2014;191(6):1863–5 e13.

    Article  PubMed  Google Scholar 

  91. Rittig S, Kamperis K, Siggaard C, Hagstroem S, Djurhuus JC. Age related nocturnal urine volume and maximum voided volume in healthy children: reappraisal of International Children’s Continence Society definitions. J Urol. 2010;183(4):1561–7.

    Article  CAS  PubMed  Google Scholar 

  92. van Doorn B, Blanker MH, Kok ET, Westers P, Bosch JL. Prevalence, incidence, and resolution of nocturnal polyuria in a longitudinal community-based study in older men: the Krimpen study. Eur Urol. 2013;63(3):542–7.

    Article  PubMed  Google Scholar 

  93. Weiss JP, Blaivas JG, Stember DS, Chaikin DC. Evaluation of the etiology of nocturia in men: the nocturia and nocturnal bladder capacity indices. Neurourol Urodyn. 1999;18(6):559–65.

    Article  CAS  PubMed  Google Scholar 

  94. van Haarst EP, Bosch JL. A cutoff value based on analysis of a reference population decreases overestimation of the prevalence of nocturnal polyuria. J Urol. 2012;188(3):869–73.

    Article  PubMed  Google Scholar 

  95. Kirkland JL, Lye M, Levy DW, Banerjee AK. Patterns of urine flow and electrolyte excretion in healthy elderly people. Br Med J. 1983;287(6406):1665–7.

    Article  CAS  Google Scholar 

  96. Asplund R, Sundberg B, Bengtsson P. Desmopressin for the treatment of nocturnal polyuria in the elderly: a dose titration study. Br J Urol. 1998;82(5):642–6.

    Article  CAS  PubMed  Google Scholar 

  97. Blanker MH, Bernsen RMD, Bosch JLHR, Thomas S, Groeneveld FP, Prins A, et al. Relation between nocturnal voiding frequency and nocturnal urine production in older men: a population-based study. Urology. 2002;60(4):612–6.

    Article  PubMed  Google Scholar 

  98. Burton C, Weiss JP, Parsons M, Blaivas JG, Coats AC. Reference values for the nocturnal bladder capacity index. Neurourol Urodyn. 2011;30(1):52–7.

    Article  PubMed  Google Scholar 

  99. Bosch JL, Everaert K, Weiss JP, Hashim H, Rahnama’i MS, Goessaert AS, et al. Would a new definition and classification of nocturia and nocturnal polyuria improve our management of patients? ICI-RS 2014. Neurourol Urodyn. 2015;35(2):283–7.

    Article  PubMed  Google Scholar 

  100. Avulova S, Blanker MH, van Doorn B, Weiss JP, Bosch JL, Tsui JF, et al. Determinants of nocturia severity in men, derived from frequency-volume charts. Scand J Urol. 2015;49(2):185–8.

    Article  PubMed  Google Scholar 

  101. Marshall SD, Raskolnikov D, Blanker MH, Hashim H, Kupelian V, Tikkinen KA, et al. Nocturia: current levels of evidence and recommendations from the international consultation on male lower urinary tract symptoms. Urology. 2015;85(6):1291–9.

    Article  PubMed  Google Scholar 

  102. Goessaert AS, Everaert K, Hoebeke P, Kapila A, Walle JV. Nocturnal enuresis and nocturia, differences and similarities - lessons to learn? Acta Clin Belg. 2014;70(2):81–6. https://doi.org/10.1179/2295333714Y.0000000055.

    Article  PubMed  Google Scholar 

  103. Kaplan SA, Wein AJ, Staskin DR, Roehrborn CG, Steers WD. Urinary retention and post-void residual urine in men: separating truth from tradition. J Urol. 2008;180(1):47–54.

    Article  PubMed  Google Scholar 

  104. Barry MJ, Fowler FJ Jr, Bin L, Pitts JC 3rd, Harris CJ, Mulley AG Jr. The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists. J Urol. 1997;157(1):10–4. discussion 4-5.

    Article  CAS  PubMed  Google Scholar 

  105. Cathcart P, van der Meulen J, Armitage J, Emberton M. Incidence of primary and recurrent acute urinary retention between 1998 and 2003 in England. J Urol. 2006;176(1):200–4. discussion 4.

    Article  PubMed  Google Scholar 

  106. Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol. 1997;158(2):481–7.

    Article  CAS  PubMed  Google Scholar 

  107. Meigs JB, Mohr B, Barry MJ, Collins MM, McKinlay JB. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol. 2001;54(9):935–44.

    Article  CAS  PubMed  Google Scholar 

  108. Verhamme KM, Dieleman JP, van Wijk MA, Bosch JL, Stricker BH, Sturkenboom MC. Low incidence of acute urinary retention in the general male population: the triumph project. Eur Urol. 2005;47(4):494–8.

    Article  CAS  PubMed  Google Scholar 

  109. Armitage J. The epidemiology and management of acute urinary retention: a study based on hospital episode statistics and systematic literature review. London: University College London; 2011.

    Google Scholar 

  110. Emberton M, Cornel EB, Bassi PF, Fourcade RO, Gomez JM, Castro R. Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management. Int J Clin Pract. 2008;62(7):1076–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  111. Fitzpatrick JM, Kirby RS. Management of acute urinary retention. BJU Int. 2006;97(Suppl 2):16–20. discussion 1-2.

    Article  PubMed  Google Scholar 

  112. Roehrborn CG, McConnell JD, Lieber M, Kaplan S, Geller J, Malek GH, et al. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group. Urology. 1999;53(3):473–80.

    Article  CAS  PubMed  Google Scholar 

  113. George NJ, O’Reilly PH, Barnard RJ, Blacklock NJ. High pressure chronic retention. Br Med J (Clin Res Ed). 1983;286(6380):1780–3.

    Article  CAS  Google Scholar 

  114. Abrams PH, Dunn M, George N. Urodynamic findings in chronic retention of urine and their relevance to results of surgery. Br Med J. 1978;2(6147):1258–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Badenoch AW. Congenital obstruction at the bladder neck. Ann R Coll Surg Engl. 1949;4(5):295–307.

    CAS  PubMed  PubMed Central  Google Scholar 

  116. Choong S, Emberton M. Acute urinary retention. BJU Int. 2000;85(2):186–201.

    Article  CAS  PubMed  Google Scholar 

  117. Mishra VC, Allen DJ, Nicolaou C, Sharif H, Hudd C, Karim OM, et al. Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? BJU Int. 2007;100(2):327–31.

    Article  PubMed  Google Scholar 

  118. Tuncel A, Uzun B, Eruyar T, Karabulut E, Seckin S, Atan A. Do prostatic infarction, prostatic inflammation and prostate morphology play a role in acute urinary retention? Eur Urol. 2005;48(2):277–83. discussion 83-4.

    Article  PubMed  Google Scholar 

  119. Emberton M, Fitzpatrick JM. The Reten-World survey of the management of acute urinary retention: preliminary results. BJU Int. 2008;101(Suppl 3):27–32.

    Article  PubMed  Google Scholar 

  120. Spiro LH, Labay G, Orkin LA. Prostatic infarction. Role in acute urinary retention. Urology. 1974;3(3):345–7.

    Article  CAS  PubMed  Google Scholar 

  121. Anjum I, Ahmed M, Azzopardi A, Mufti GR. Prostatic infarction/infection in acute urinary retention secondary to benign prostatic hyperplasia. J Urol. 1998;160(3 Pt 1):792–3.

    Article  CAS  PubMed  Google Scholar 

  122. McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M, Holtgrewe HL, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med. 1998;338(9):557–63.

    Article  CAS  PubMed  Google Scholar 

  123. Armitage J, Emberton M. Is it time to reconsider the role of prostatic inflammation in the pathogenesis of lower urinary tract symptoms? BJU Int. 2005;96(6):745–6.

    Article  PubMed  Google Scholar 

  124. Roehrborn CG, Malice M, Cook TJ, Girman CJ. Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: a comprehensive analysis of the pooled placebo groups of several large clinical trials. Urology. 2001;58(2):210–6.

    Article  CAS  PubMed  Google Scholar 

  125. Ghalayini IF, Al-Ghazo MA, Pickard RS. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention. BJU Int. 2005;96(1):93–7.

    Article  PubMed  Google Scholar 

  126. Pruthi RS. The dynamics of prostate-specific antigen in benign and malignant diseases of the prostate. BJU Int. 2000;86(6):652–8.

    Article  CAS  PubMed  Google Scholar 

  127. Bates TS, Sugiono M, James ED, Stott MA, Pocock RD. Is the conservative management of chronic retention in men ever justified? BJU Int. 2003;92(6):581–3.

    Article  CAS  PubMed  Google Scholar 

  128. McNeill SA, Hargreave TB, Roehrborn CG. Alfaur study g. Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study. Urology. 2005;65(1):83–9. discussion 9-90.

    Article  CAS  PubMed  Google Scholar 

  129. McNeill SA, Daruwala PD, Mitchell ID, Shearer MG, Hargreave TB. Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled. BJU Int. 1999;84(6):622–7.

    Article  CAS  PubMed  Google Scholar 

  130. O’Brien WM. Percutaneous placement of a suprapubic tube with peel away sheath introducer. J Urol. 1991;145(5):1015–6.

    Article  PubMed  Google Scholar 

  131. Mohammed A, Khan A, Shergill IS, Gujral SS. A new model for suprapubic catheterization: the MediPlus Seldinger suprapubic catheter. Expert Rev Med Devices. 2008;5(6):705–7.

    Article  PubMed  Google Scholar 

  132. Ramos-Fernandez MR, Medero-Colon R, Mendez-Carreno L. Critical urologic skills and procedures in the emergency department. Emerg Med Clin North Am. 2013;31(1):237–60.

    Article  PubMed  PubMed Central  Google Scholar 

  133. Harrison SC, Lawrence WT, Morley R, Pearce I, Taylor J. British Association of Urological Surgeons’ suprapubic catheter practice guidelines. BJU Int. 2011;107(1):77–85.

    Article  PubMed  Google Scholar 

  134. Horgan AF, Prasad B, Waldron DJ, O’Sullivan DC. Acute urinary retention. Comparison of suprapubic and urethral catheterisation. Br J Urol. 1992;70(2):149–51.

    Article  CAS  PubMed  Google Scholar 

  135. Ahluwalia RS, Johal N, Kouriefs C, Kooiman G, Montgomery BS, Plail RO. The surgical risk of suprapubic catheter insertion and long-term sequelae. Ann R Coll Surg Engl. 2006;88(2):210–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  136. Ichsan J, Hunt DR. Suprapubic catheters: a comparison of suprapubic versus urethral catheters in the treatment of acute urinary retention. Aust N Z J Surg. 1987;57(1):33–6.

    Article  CAS  PubMed  Google Scholar 

  137. Shergill IS, Shaikh T, Arya M, Junaid I. A training model for suprapubic catheter insertion: the UroEmerge suprapubic catheter model. Urology. 2008;72(1):196–7.

    Article  PubMed  Google Scholar 

  138. Ahmed SJ, Mehta A, Rimington P. Delayed bowel perforation following suprapubic catheter insertion. BMC Urol. 2004;4(1):16.

    Article  PubMed  PubMed Central  Google Scholar 

  139. Abrams PH, Shah PJ, Gaches CG, Ashken MH, Green NA. Role of suprapubic catheterization in retention of urine. J R Soc Med. 1980;73(12):845–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  140. Manikandan R, Srirangam SJ, O’Reilly PH, Collins GN. Management of acute urinary retention secondary to benign prostatic hyperplasia in the UK: a national survey. BJU Int. 2004;93(1):84–8.

    Article  CAS  PubMed  Google Scholar 

  141. Zeif HJ, Subramonian K. Alpha blockers prior to removal of a catheter for acute urinary retention in adult men. Cochrane Database Syst Rev. 2009;4:CD006744.

    Google Scholar 

  142. Karavitakis M, Kyriazis I, Omar MI, Gravas S, Cornu JN, Drake MJ, et al. Management of urinary retention in patients with benign prostatic obstruction: a systematic review and meta-analysis. Eur Urol. 2019;75(5):788–98.

    Article  PubMed  Google Scholar 

  143. Hedlund H, Hjelmas K, Jonsson O, Klarskov P, Talja M. Hydrophilic versus non-coated catheters for intermittent catheterization. Scand J Urol Nephrol. 2001;35(1):49–53.

    Article  CAS  PubMed  Google Scholar 

  144. Yuh B, Laungani R, Perlmutter A, Eun D, Peabody JO, Mohler JL, et al. Robot-assisted Millin’s retropubic prostatectomy: case series. Can J Urol. 2008;15(3):4101–5.

    PubMed  Google Scholar 

  145. Tan A, Liao C, Mo Z, Cao Y. Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction. Br J Surg. 2007;94(10):1201–8.

    Article  CAS  PubMed  Google Scholar 

  146. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol. 2006;20(8):580–5.

    Article  PubMed  Google Scholar 

  147. Guo S, Muller G, Lehmann K, Talimi S, Bonkat G, Puschel H, et al. The 80-W KTP GreenLight laser vaporization of the prostate versus transurethral resection of the prostate (TURP): adjusted analysis of 5-year results of a prospective non-randomized bi-center study. Lasers Med Sci. 2015;30(3):1147–51.

    Article  PubMed  Google Scholar 

  148. McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349(25):2387–98.

    Article  CAS  PubMed  Google Scholar 

  149. Roehrborn CG, Siami P, Barkin J, Damiao R, Major-Walker K, Nandy I, et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol. 2010;57(1):123–31.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Addenbrookes Teaching Hospitals NHS Trust, Cambridge, UK

    Suzanne Biers

  2. University of Groningen, Groningen, Netherlands

    Marco H. Blanker

  3. São João University Hospital and University of Porto, Porto, Portugal

    N. Dias

  4. Lister Hospital, Stevenage, UK

    Charlotte Foley

  5. Royal Free Hospital, London, UK

    Aziz Gulamhusein

  6. Radboudumc Amalia Children’s Hospital, Radboud University Medical Center, Nijmegen, Netherlands

    Ilse Hofmeester

  7. Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan

    Han-Chorn Kuo & Cheng-Ling Lee

  8. Sheffield Teaching Hospitals NHS Trust, Royal Hallamshire Hospital, Sheffield, UK

    Nadir I. Osman

  9. Chelsea and Westminster Hospital NHS Foundation Trust, London, UK

    Shiv Kumar Pandian

  10. Centro Hospitalar do Porto, Porto, Portugal

    Rui Pinto

  11. Guy’s and Thomas’s Hospital, London, UK

    Richard John Popert

  12. Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal

    Ricardo Pereira e Silva

Authors
  1. Suzanne Biers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marco H. Blanker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Dias
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Charlotte Foley
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Aziz Gulamhusein
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ilse Hofmeester
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Han-Chorn Kuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Cheng-Ling Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Nadir I. Osman
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Shiv Kumar Pandian
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Rui Pinto
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Richard John Popert
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Ricardo Pereira e Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Urology, University of Bristol, Bristol, UK

    Marcus Drake

  2. Department of Urology, Careggi Hospital, University of Florence, Florence, Italy

    Andrea Cocci

  3. Faculdade de Medicina de Lisboa, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal

    Ricardo Pereira e Silva

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Biers, S. et al. (2020). Conditions and Syndromes. In: Drake, M., Cocci, A., Pereira e Silva, R. (eds) Lower Urinary Tract Symptoms in Adults. Springer, Cham. https://doi.org/10.1007/978-3-030-27747-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-27747-5_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-27745-1

  • Online ISBN: 978-3-030-27747-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation